People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Other Health Care, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spine BioPharma, Inc. | — | Pharmaceuticals | Series A | $51.8M | $63.8M | 2021 |
| Paradigm Spine Llc | — | Other Health Care | Series B | $44.5M | $221.5M | 2009 |
| Viscogliosi Brothers Venture Partners III, LLC | — | Other Health Care | Series B | $25.0M | $553.9M | 2010 |
| Knee Creations, LLC | — | Other Health Care | Series A | $15.6M | $131.2M | 2009 |
| Companion Spine, LLC | — | Pharmaceuticals | Series A | $8.5M | $58.9M | 2023 |
| Viscogliosi Brothers Venture Partners IV, LLC | — | Other Health Care | Series A | $8.5M | $20.0M | — |
| Ni-Q, LLC | — | Other | Seed | $6.5M | $68.9M | 2016 |
| AFCell Medical, Inc. | — | Biotechnology | Seed | $2.6M | $6.7M | 2011 |
Marc R. Viscogliosi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marc R. Viscogliosi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.